ArticlePloS one2015

The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways.

Bruno A Cardoso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.